[The influence of the HIV pandemic on the incidence of malignant ocular tumours in Southern Malawi (Blantyre)].
BACKGROUND
The HIV pandemic in Southeast Africa is a challenge to the poorly staffed and poorly financed health systems of the affected countries. A dramatic increase of HIV-associated ocular malignancies has been observed in Malawi. This study investigated the frequency of malignant ocular tumours at the only eye hospital in the south of Malawi.


METHODS
A retrospective analysis of all patients who underwent removal of conjunctival growth suspicious for malignancy was performed for the period from 1989 to 2006. In addition a consecutive group of 49 patients with malignant ocular tumours was offered an HIV test.


RESULTS
The number of patients undergoing surgery for suspected ocular surface squamous neoplasia (OSSN) increased from 32 cases in 1989 to 467 in 2006. Of the patients with malignant ocular tumours, 80% (39 of 49) had OSSN, and 76% of the patients with OSSN were HIV positive.


CONCLUSIONS
OSSN has become the most frequent malignant ocular tumour in the south of Malawi. The incidence of OSSN seems to have increased dramatically from 1989 to 2006--in parallel to increasing HIV infection rates.
Spitzer
M S
MS
Zentrum für Augenheilkunde, Universitäts-Augenklinik Tübingen, Schleichstrasse 12, Tübingen. martin.spitzer@med.uni-tuebingen.de
Chirambo
T
T
Kayange
P
P
Szurman
P
P
Yoeruek
E
E
Bartz-Schmidt
K U
KU
Batumba
H N
HN
D000293:Adolescent; D000328:Adult; D015984:Causality; D015897:Comorbidity; D004196:Disease Outbreaks / Q000706:statistics & numerical data*; D005134:Eye Neoplasms / Q000175:diagnosis / Q000453:epidemiology*; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008295:Malawi / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D055815:Young Adult
Sex Transm Infect. 2006 Apr;82 Suppl 1:i9-13
16581763
Ophthalmologe. 2004 Sep;101(9):941-4
14999411
Lancet. 1996 May 25;347(9013):1450-1
8676629
Ophthalmologe. 2004 Oct;101(10):1011-6
15185119
East Afr Med J. 2006 May;83(5):267-70
16866221
Br J Ophthalmol. 2007 Jan;91(1):120-1
17179130
Cornea. 2003 Jan;22(1):1-4
12502938
Nature. 1999 Feb 4;397(6718):436-41
9989410
Am J Ophthalmol. 1970 Nov;70(5):757-63
5477165
Lancet. 1995 Mar 18;345(8951):695-6
7885126
Br J Ophthalmol. 1996 Jun;80(6):503-8
8759259
Clin Exp Ophthalmol. 2008 Jul;36(5):422-5
18939345
Pediatr Blood Cancer. 2007 May;48(5):515-20
16794998
Br J Cancer. 2002 Jul 29;87(3):301-8
12177799
Int Ophthalmol. 1990 May;14(3):165-72
2188917
Ann Trop Med Parasitol. 2006 Jul-Sep;100(5-6):433-54
16899147
Cancer. 1967 Oct;20(10):1689-98
6058176
Br J Ophthalmol. 1999 Feb;83(2):177-9
10396194
Eye (Lond). 2006 Aug;20(8):893-9
16456599
Mutagenesis. 2004 Sep;19(5):399-401
15388813
Eye (Lond). 2006 Dec;20(12):1414-5; author reply 1415
16456584
Surv Ophthalmol. 1995 May-Jun;39(6):429-50
7660300
Klin Monbl Augenheilkd. 1995 Oct;207(4):239-46
8587298
Int J STD AIDS. 2005 Dec;16(12):782-3
16336757